S. Caldiera

599 total citations
22 papers, 468 citations indexed

About

S. Caldiera is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Rheumatology. According to data from OpenAlex, S. Caldiera has authored 22 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 7 papers in Rheumatology. Recurrent topics in S. Caldiera's work include Eosinophilic Disorders and Syndromes (4 papers), Nutrition and Health in Aging (4 papers) and Frailty in Older Adults (3 papers). S. Caldiera is often cited by papers focused on Eosinophilic Disorders and Syndromes (4 papers), Nutrition and Health in Aging (4 papers) and Frailty in Older Adults (3 papers). S. Caldiera collaborates with scholars based in Italy, United States and Switzerland. S. Caldiera's co-authors include Paolo Foa, Andrea Luciani, Daris Ferrari, S. Zonato, Carla Codecà, Irene Floriani, Tiziana Ascione, Giuseppe Di Maria, Monica Fornier and Ignazio Cataldo and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and Annals of Oncology.

In The Last Decade

S. Caldiera

19 papers receiving 458 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Caldiera Italy 11 173 145 115 91 90 22 468
Shripad Banavali India 13 145 0.8× 180 1.2× 44 0.4× 28 0.3× 67 0.7× 37 483
Regina Gironés Spain 16 313 1.8× 273 1.9× 150 1.3× 98 1.1× 68 0.8× 47 666
Chiara Bottelli Italy 11 307 1.8× 53 0.4× 171 1.5× 120 1.3× 56 0.6× 24 685
Jong Seok Lee South Korea 12 215 1.2× 146 1.0× 37 0.3× 32 0.4× 66 0.7× 18 478
Aytuğ Üner Türkiye 15 400 2.3× 189 1.3× 31 0.3× 144 1.6× 131 1.5× 70 786
Isabella Capodanno Italy 10 203 1.2× 164 1.1× 26 0.2× 28 0.3× 29 0.3× 22 611
Dirk K.M. De Ruysscher Netherlands 15 330 1.9× 385 2.7× 22 0.2× 71 0.8× 55 0.6× 46 701
R. Blanco Spain 9 282 1.6× 227 1.6× 26 0.2× 19 0.2× 47 0.5× 12 511
Danila Comandini Italy 11 269 1.6× 191 1.3× 35 0.3× 29 0.3× 29 0.3× 31 446
Soojung Hong South Korea 13 292 1.7× 195 1.3× 11 0.1× 24 0.3× 82 0.9× 35 501

Countries citing papers authored by S. Caldiera

Since Specialization
Citations

This map shows the geographic impact of S. Caldiera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Caldiera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Caldiera more than expected).

Fields of papers citing papers by S. Caldiera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Caldiera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Caldiera. The network helps show where S. Caldiera may publish in the future.

Co-authorship network of co-authors of S. Caldiera

This figure shows the co-authorship network connecting the top 25 collaborators of S. Caldiera. A scholar is included among the top collaborators of S. Caldiera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Caldiera. S. Caldiera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ferrari, Daris, Carla Codecà, Maria Di Blasi, et al.. (2016). Radiotherapy and cetuximab for elderly patients affected by loco-regionally advanced head and neck cancer. Annals of Oncology. 27. iv88–iv88.
2.
Ferrari, Daris, Carla Codecà, Giulia Viale, et al.. (2015). Anti-epidermal growth factor receptor skin toxicity. Anti-Cancer Drugs. 27(2). 144–146. 3 indexed citations
3.
Luciani, Andrea, Antonella Brunello, Giovanna Romanato, et al.. (2015). The assessment of chemotherapy risk in elderly cancer patients: Validation of the CRASH score in an Italian cohort.. Journal of Clinical Oncology. 33(15_suppl). e20521–e20521. 2 indexed citations
4.
Ferrari, Daris, Carla Codecà, Nicolò Matteo Luca Battisti, et al.. (2014). Multimodality treatment of osteosarcoma of the jaw: a single institution experience. Medical Oncology. 31(9). 171–171. 21 indexed citations
5.
Savi, Federica, Irene Forno, Alice Faversani, et al.. (2014). miR-296/Scribble axis is deregulated in human breast cancer and miR-296 restoration reduces tumour growth in vivo. Clinical Science. 127(4). 233–242. 38 indexed citations
6.
Luciani, Andrea, Lorenzo Dottorini, Nicolò Matteo Luca Battisti, et al.. (2012). Screening elderly cancer patients for disabilities: evaluation of study of osteoporotic fractures (SOF) index and comprehensive geriatric assessment (CGA). Annals of Oncology. 24(2). 469–474. 20 indexed citations
7.
Luciani, Andrea, Tiziana Ascione, Carla Codecà, et al.. (2010). Detecting Disabilities in Older Patients With Cancer: Comparison Between Comprehensive Geriatric Assessment and Vulnerable Elders Survey-13. Journal of Clinical Oncology. 28(12). 2046–2050. 146 indexed citations
8.
Ferrari, Daris, Carla Codecà, Giuseppe Di Maria, et al.. (2009). A phase II study of carboplatin and paclitaxel for recurrent or metastatic head and neck cancer. Anti-Cancer Drugs. 20(3). 185–190. 21 indexed citations
9.
Luciani, Andrea, Tiziana Ascione, S. Caldiera, et al.. (2008). Clinical analysis of multiple primary malignancies in the elderly. Medical Oncology. 26(1). 27–31. 23 indexed citations
10.
Luciani, Andrea, Luca Tagliabue, Carla Codecà, et al.. (2008). The impact of chemotherapy on sarcopenia and fatigue in elderly cancer patients: A prospective pilot study. Journal of Clinical Oncology. 26(15_suppl). 9635–9635. 2 indexed citations
11.
Luciani, Andrea, Tiziana Ascione, S. Caldiera, et al.. (2006). Do Elderly Cancer Patients Achieve an Adequate Dose Intensity in Common Clinical Practice?. Oncology. 71(5-6). 382–387. 4 indexed citations
12.
Sessa, Cristiana, C. Cuvier, S. Caldiera, et al.. (2002). Phase I clinical and pharmacokinetic studies of the taxoid derivative RPR 109881A administered as a 1-hour or a 3-hour infusion in patients with advanced solid tumors. Annals of Oncology. 13(7). 1140–1150. 37 indexed citations
13.
Spataro, Vito, et al.. (2000). ADENOCARCINOMA OF THE RETE TESTIS. The Journal of Urology. 164(4). 1307–1308. 11 indexed citations
14.
Spataro, Vito, et al.. (2000). ADENOCARCINOMA OF THE RETE TESTIS. The Journal of Urology. 1307–1308.
15.
Foà, P. P., Monica Fornier, Rosalba Miceli, et al.. (1999). Preoperative CEA, NSE, SCC, TPA and CYFRA 21.1 Serum Levels as Prognostic Indicators in Resected Non-Small Cell Lung Cancer. The International Journal of Biological Markers. 14(2). 92–98. 9 indexed citations
16.
Caldiera, S., Alessandra Iurlo, Carlo Alfredo Clerici, et al.. (1998). Long‐term therapeutic efficacy and toxicity of recombinant interferon‐alpha 2a in polycythaemia vera. European Journal Of Haematology. 60(5). 273–277. 17 indexed citations
17.
Fornier, Monica, et al.. (1997). Palmar-Plantar Erythrodysaesthesia Syndrome Due to 5-Fluorouracil Therapy–An Underestimated Toxic Event?. Acta Oncologica. 36(6). 653–654. 6 indexed citations
18.
Foa, Paolo, Mauro Pomati, Alessandra Iurlo, et al.. (1997). Polycythemia vera treated with recombinant interferon-alpha 2a: Evidence of a selective effect on the malignant clone. American Journal of Hematology. 56(2). 126–128. 28 indexed citations
20.
Damilano, I, et al.. (1996). Chronic myeloid leukemia treated with busulfan. Oncology Reports. 3(6). 1067–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026